Cancer Genetics (CGIX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/2/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Cancer Genetics Announces Strong Second Quarter 2015 Results
August 11, 2015 7:30 AM EDTSecond Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award of Largest Clinical Trial in Company's History Further Validation of CGI's Bench to Bedside Strategy Secured strategic alliance with ICON plc, a global CRO for the biopharma community Announced that it has entered into an agreement to acquire assets and operations of Response Genetics, Inc. (OTCQB: RGDX)
RUTHERFORD, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in... More
Cancer Genetics Announces Strong Second Quarter 2015 Results
August 11, 2015 7:30 AM EDTSecond Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award of Largest Clinical Trial in Company's History Further Validation of CGI's Bench to Bedside Strategy Secured strategic alliance with ICON plc, a global CRO for the biopharma community Announced that it has entered into an agreement to acquire assets and operations of Response Genetics, Inc. (OTCQB: RGDX)
RUTHERFORD, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in... More
